The news: Rippl, a Seattle startup focused on the mental health of seniors, launched Wednesday with $32 million in seed funding. The company is developing a care program focused on… Read More
ARCH Venture Partners has closed a $2.975 billion fund targeted for early-stage biotech companies. The firm’s 12th venture fund comes on the heels of a nearly $2 billion fund announced… Read More
When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of remissions in leukemia patients treated with their own immune cells,… Read More
Robert Nelsen may not be a household name in venture capital circles — certainly not the way that Reid Hoffman, John Doerr and Fred Wilson are known. But the Seattle… Read More